| Product Code: ETC13340763 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America mRNA Therapeutics Contract Development Manufacturing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 North America mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 North America mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 North America mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 North America mRNA Therapeutics Contract Development Manufacturing Market, 2021 - 2031 |
6.1 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Process Development, 2021 - 2031 |
6.1.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Analytical Testing, 2021 - 2031 |
6.1.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
6.1.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Formulation Development, 2020 - 2028 |
6.1.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Regulatory Support, 2020 - 2028 |
6.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Vaccines, 2021 - 2031 |
6.2.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Therapeutics, 2021 - 2031 |
6.2.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031 |
6.2.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Protein Replacement Therapy, 2020 - 2028 |
6.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Cancer Treatment, 2021 - 2031 |
6.3.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Rare Diseases, 2021 - 2031 |
6.3.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Autoimmune Diseases, 2021 - 2031 |
6.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.4.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Contract Manufacturing Organizations, 2020 - 2028 |
6.4.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Clinical Research Organizations, 2020 - 2028 |
6.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Lipid Nanoparticles, 2020 - 2028 |
6.5.3 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By In Vitro Transcription, 2020 - 2028 |
6.5.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Encapsulation Methods, 2020 - 2028 |
6.5.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By CRISPR Technology, 2020 - 2028 |
6.5.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By AI-Based Quality Control, 2020 - 2028 |
7 North America mRNA Therapeutics Contract Development Manufacturing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 North America mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United States (US) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Canada mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Rest of North America mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 North America mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
9 North America mRNA Therapeutics Contract Development Manufacturing Market - Export/Import By Countries Assessment |
10 North America mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
10.1 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 North America mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
11.1 North America mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2022 |
11.2 North America mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here